Long COVID Hits the Young Harder Than the Old, Study Finds
By Ernie Mundell HealthDay Reporter
MONDAY, Nov. 25, 2024 -- It might sound counterintuitive, but new research shows that when Long COVID strikes, younger patients appear more prone to severe symptoms than older folks.
That's tough on society as a whole, the study's lead author said.
“The impact of Long COVID is causing disproportionate morbidity [illness] and disability in younger adults in their prime who provide much of the workforce, productivity and innovation in our society,” said Dr. Igor Koralnik. He co-directs the Northwestern Medicine Comprehensive COVID-19 Center, in Chicago.
According to the researchers, neurological symptoms of Long COVID can include headache, numbness and tingling, problems with smell and taste, blurred vision, depression, anxiety, insomnia, fatigue and a decrease in cognitive function.
“While deaths from COVID-19 continue to decrease, people still get repetitive infections with the virus and may develop Long COVID along the way,” said Koralnik, who is also chief of neuroinfectious diseases and global neurology at Northwestern Medicine.
“Long COVID is causing an alteration in patients’ quality of life," he said. "Despite vaccinations and boosters, about 30 percent of COVID patients develop some Long COVID symptoms."
The new study was published Nov. 22 in the Annals of Neurology. It involved the first 1,300 patients diagnosed with Long COVID and cared for at the Northwestern COVID clinic.
As the researchers noted, only 200 of those patients had initial COVID-19 symptoms so severe (for example, pneumonia) that they required hospitalization.
Researchers tracked patient outcomes for an average of 10 months after the onset of their initial bout with COVID.
They found that the neurological symptoms of people with Long COVID tended to be more pronounced if they were under 65, compared to those experienced by older individuals.
An array of neurological symptoms often occurred, regardless of how severe the patient's initial case of COVID-19 had been, the Chicago team added.
"This study highlights the importance that people of all ages suffering from Long COVID should be provided with the necessary treatment and rehabilitation services to alleviate their symptoms and improve their quality of life," Koralnik said in a Northwestern news release.
Sources
- Northwestern Medicine, news release, Nov. 22, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
FDA Authorizes First AI Platform for Breast Cancer Prediction
FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...
4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone
FRIDAY, June 6, 2025 — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in...
Long-Lasting HIV Prevention Shot Headed Toward Approval
FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.